Zafirlukast is a broad‐spectrum thiol isomerase inhibitor that inhibits thrombosis without altering bleeding times-Reference-Cited by-同舟云学术

Zafirlukast is a broad‐spectrum thiol isomerase inhibitor that inhibits thrombosis without altering bleeding times

Published:2021-01-04 Issue:3 Volume:178 Page:550-563
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:Br J Pharmacol

Author:

Holbrook Lisa‐Marie¹²,Keeton Shirley J.¹,Sasikumar Parvathy¹³,Nock Sophie¹,Gelzinis Justine⁴,Brunt Elizabeth¹⁴,Ryan Sarah¹,Pantos Megan M.⁴,Verbetsky Christina A.⁴,Gibbins Jonathan M.¹,Kennedy Daniel R.⁴

Affiliation:

1. Institute for Cardiovascular and Metabolic Research, School of Biological Sciences University of Reading Reading UK

2. School of Cardiovascular Medicine and Sciences King's College London London UK

3. Centre for Haematology Imperial College London London UK

4. College of Pharmacy and Health Sciences Western New England University Springfield Massachusetts USA

Funder

British Heart Foundation

Medical Research Council Canada

Publisher

Wiley

Subject

Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bph.15291

Reference56 articles.

1. The Concise Guide to PHARMACOLOGY 2019/20: G protein‐coupled receptors;Alexander S. P. H.;British Journal of Pharmacology,2019

2. Expression of G protein-coupled receptors and related proteins in HEK293, AtT20, BV2, and N18 cell lines as revealed by microarray analysis

3. A substrate-driven allosteric switch that enhances PDI catalytic activity

4. Galectin-9 binding to cell surface protein disulfide isomerase regulates the redox environment to enhance T-cell migration and HIV entry

5. A critical role for extracellular protein disulfide isomerase during thrombus formation in mice;Cho J.;The Journal of Clinical Investigation,2008

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PDIA6andMaspinin Prostate Cancer;Anticancer Research;2023-11-29

2. Zafirlukast protects against hepatic ischemia–reperfusion injury in rats via modulating Bcl-2/Bax and NF-κB/SMAD-4 pathways;International Immunopharmacology;2023-09

3. Targeting thiol isomerase activity with zafirlukast to treat ovarian cancer from the bench to clinic;The FASEB Journal;2023-04-12

4. In Vitro Activity of Peptide Antibiotics in Combination With Other Antimicrobials on Extensively Drug-Resistant Acinetobacter baumannii in the Planktonic and Biofilm Cell;Frontiers in Pharmacology;2022-05-11

5. Zafirlukast inhibits the growth of lung adenocarcinoma via inhibiting TMEM16A channel activity;Journal of Biological Chemistry;2022-03